Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:59 AM
Ignite Modification Date:
2025-12-24 @ 11:59 AM
NCT ID:
NCT04486261
Eligibility Criteria:
Inclusion Criteria:
* Fulfilling the criteria for myositis by EULAR/ACR (Bottai et al., 2017; Lundberg et al., 2017)
* ≤ 5 mg/day Prednisolone
* Stable dosage of immunosuppressive treatment for at least 1 months prior to inclusion in the study
* Myositis diagnosis at least 6 months prior to inclusion in the study
Exclusion Criteria:
* Patients with sporadic inclusion body myositis and overlap myositis (myositis combined with another autoimmune rheumatic diseases, except Sjögren's Syndrome)
* Co-morbidity preventing resistance training (severe heart/lung-disease, uncontrolled hypertension (systolic \> 160mmHg, diastolic \> 100mmHg), severe knee/hip arthritis)
* Alcohol- and/or drug abuse. Defined by the guidelines issued by The Danish Health Authority
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04486261
Study Brief:
Protocol Section:
NCT04486261